Radiation Oncology Grand Rounds: Proton Therapy for Esophageal Cancer
Proton Therapy for Esophageal Cancer delivers higher, more effective doses of radiation than traditional X-ray radiation therapy with great precision, significantly limiting radiation exposure to surrounding healthy tissue near the esophagus.
Dr. Lin will discuss the importance of identifying patient selection for proton therapy.
Target Audience
Radiation Oncologists, Medical Oncologists, Oncology Surgeons and Radiologists
NOTE: Due to limited space, this conference is open to Baptist Health affiliated Medical Staff and Clinical Employees.
Learning Objectives
- Critically appraise the importance of precise and high quality radiotherapy in the management of esophageal cancer.
- Identify the benefits of proton therapy and type of selection strategies to optimize the use of proton therapy in esophageal cancer.
Steven H. Lin, M.D., Ph.D.
Associate Professor of Radiation Oncology
MD Anderson Cancer Center
Houston, Texas
Steven H. Lin, M.D., Ph.D., indicated that he has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Grant/Research: Genentech, Hitachi Chemical Diagnostic, Peregrine Pharmaceuticals, New River Labs, BeyondSpring Pharmaceuticals
Other Financial or Material Support: AstraZeneca
Michael Chuong, M.D. Non-faculty contributors and others involved in the planning, development, and editing/review of the content have relevant financial relationships to disclose.
Dr. Chuong is a consultant with QuantiaMD. He will not include off-label or unapproved product usage in his discussions.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 1 credit hour, CE Broker Course #20-621028, by the Florida Boards of Medicine and Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity has also been approved for 1 credit hour for Nurses and Nurse Practitioners and Respiratory Care (personal growth). Baptist Health South Florida CE Broker Provider #50-182.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Respiratory Therapy
NOTE: Due to limited space, this conference is open to Baptist Health affiliated Medical Staff and Clinical Employees.
Required Hardware/Software
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to [email protected] and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.